Food & Function-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2192816, encodeId=3dc8219281653, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢组学 经验分享：2023.9.25投稿，2024.1.5第一次大修，1.30修回。2.8第二次大修，3.11接收。审稿人很负责, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Mar 12 16:44:35 CST 2024, time=2024-03-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=556031, encodeId=279e556031c3, content=历时4个多月，终于接收。 12.16投稿； 4.23大修； 5.9 返回； 5.11 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd6c2222639, createdName=mr.wu1992, createdTime=Sun May 13 12:19:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548940, encodeId=e85754894045, content=7月28日投稿，10月13日回复审稿意见，28日修回，五天后接收，审稿人很认真负责。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23de1733516, createdName=nbcc14, createdTime=Mon Nov 06 11:05:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843279, encodeId=fc598432e901, content=3月31投稿 4月6号外审 5月9号返回意见，小修 5月16号修回 5月21号接受 整体来说还是挺快的，给的意见也很中肯 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5414079, createdName=ms3478754100835653, createdTime=Mon May 21 23:52:17 CST 2018, time=2018-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181435, encodeId=42822181435d2, content=偏重的研究方向：药理 经验分享：11月24号投稿，12月16号收到大修通知，1月4号修回，1月10号accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Sat Jan 13 18:57:40 CST 2024, time=2024-01-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2119100, encodeId=8b9f2119100e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：食品;功能食品;肽 经验分享：Food Function 很快的一次经历，感谢编辑和审稿人 2023.1.09 投稿 2023.1.23 under review 第一审稿人出现 2023.1.26 第一审稿人完成 2023.1.29 第二第三审稿人出现 2023.2.9 第两个审稿人完成. 2023.2.14 大修，三个审稿人 2023.2.25 修回🙏 2023.3.2 送回审稿人！！ 2023.3.12 接受！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Sun Mar 12 17:59:47 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2102239, encodeId=738b210223955, content=我已经投出去快3个月了，一会在with editor, 一会在in peer view, 这是什么状态，请问我要不要催一下编辑？大家能给点建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79e94751065, createdName=adidas521521, createdTime=Wed Nov 23 21:00:45 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591166, encodeId=f68e591166ed, content=请问With editor一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f422038027, createdName=1821e90a65m, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854575, encodeId=b6448545e5c3, content=审稿速度:5.0 经验分享：5月份投稿，2个月的with editor才送审，期间大修返修过一次，10月11号小修修回，至今还是with editor，真的有点慢呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf15414154, createdName=ms3508121495608353, createdTime=Tue Oct 29 20:11:14 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583574, encodeId=35ce5835e448, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：降为2区了，再让这样灌水下去，3区都不保，很多1分水平的也给送审，还喜欢送给国人审！最近又审了3篇，2篇就cscd水平，让补一大堆数据给拒了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=)]

2024-03-12 ms8000001972745472 来自河南省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：代谢组学
经验分享：2023.9.25投稿，2024.1.5第一次大修，1.30修回。2.8第二次大修，3.11接收。审稿人很负责

12 0

[GetPortalCommentsPageByObjectIdResponse(id=2192816, encodeId=3dc8219281653, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢组学 经验分享：2023.9.25投稿，2024.1.5第一次大修，1.30修回。2.8第二次大修，3.11接收。审稿人很负责, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Mar 12 16:44:35 CST 2024, time=2024-03-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=556031, encodeId=279e556031c3, content=历时4个多月，终于接收。 12.16投稿； 4.23大修； 5.9 返回； 5.11 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd6c2222639, createdName=mr.wu1992, createdTime=Sun May 13 12:19:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548940, encodeId=e85754894045, content=7月28日投稿，10月13日回复审稿意见，28日修回，五天后接收，审稿人很认真负责。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23de1733516, createdName=nbcc14, createdTime=Mon Nov 06 11:05:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843279, encodeId=fc598432e901, content=3月31投稿 4月6号外审 5月9号返回意见，小修 5月16号修回 5月21号接受 整体来说还是挺快的，给的意见也很中肯 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5414079, createdName=ms3478754100835653, createdTime=Mon May 21 23:52:17 CST 2018, time=2018-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181435, encodeId=42822181435d2, content=偏重的研究方向：药理 经验分享：11月24号投稿，12月16号收到大修通知，1月4号修回，1月10号accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Sat Jan 13 18:57:40 CST 2024, time=2024-01-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2119100, encodeId=8b9f2119100e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：食品;功能食品;肽 经验分享：Food Function 很快的一次经历，感谢编辑和审稿人 2023.1.09 投稿 2023.1.23 under review 第一审稿人出现 2023.1.26 第一审稿人完成 2023.1.29 第二第三审稿人出现 2023.2.9 第两个审稿人完成. 2023.2.14 大修，三个审稿人 2023.2.25 修回🙏 2023.3.2 送回审稿人！！ 2023.3.12 接受！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Sun Mar 12 17:59:47 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2102239, encodeId=738b210223955, content=我已经投出去快3个月了，一会在with editor, 一会在in peer view, 这是什么状态，请问我要不要催一下编辑？大家能给点建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79e94751065, createdName=adidas521521, createdTime=Wed Nov 23 21:00:45 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591166, encodeId=f68e591166ed, content=请问With editor一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f422038027, createdName=1821e90a65m, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854575, encodeId=b6448545e5c3, content=审稿速度:5.0 经验分享：5月份投稿，2个月的with editor才送审，期间大修返修过一次，10月11号小修修回，至今还是with editor，真的有点慢呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf15414154, createdName=ms3508121495608353, createdTime=Tue Oct 29 20:11:14 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583574, encodeId=35ce5835e448, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：降为2区了，再让这样灌水下去，3区都不保，很多1分水平的也给送审，还喜欢送给国人审！最近又审了3篇，2篇就cscd水平，让补一大堆数据给拒了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=)]

2018-05-13 mr.wu1992

历时4个多月，终于接收。
12.16投稿；
4.23大修；
5.9 返回；
5.11 接收。

232 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192816, encodeId=3dc8219281653, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢组学 经验分享：2023.9.25投稿，2024.1.5第一次大修，1.30修回。2.8第二次大修，3.11接收。审稿人很负责, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Mar 12 16:44:35 CST 2024, time=2024-03-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=556031, encodeId=279e556031c3, content=历时4个多月，终于接收。 12.16投稿； 4.23大修； 5.9 返回； 5.11 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd6c2222639, createdName=mr.wu1992, createdTime=Sun May 13 12:19:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548940, encodeId=e85754894045, content=7月28日投稿，10月13日回复审稿意见，28日修回，五天后接收，审稿人很认真负责。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23de1733516, createdName=nbcc14, createdTime=Mon Nov 06 11:05:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843279, encodeId=fc598432e901, content=3月31投稿 4月6号外审 5月9号返回意见，小修 5月16号修回 5月21号接受 整体来说还是挺快的，给的意见也很中肯 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5414079, createdName=ms3478754100835653, createdTime=Mon May 21 23:52:17 CST 2018, time=2018-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181435, encodeId=42822181435d2, content=偏重的研究方向：药理 经验分享：11月24号投稿，12月16号收到大修通知，1月4号修回，1月10号accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Sat Jan 13 18:57:40 CST 2024, time=2024-01-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2119100, encodeId=8b9f2119100e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：食品;功能食品;肽 经验分享：Food Function 很快的一次经历，感谢编辑和审稿人 2023.1.09 投稿 2023.1.23 under review 第一审稿人出现 2023.1.26 第一审稿人完成 2023.1.29 第二第三审稿人出现 2023.2.9 第两个审稿人完成. 2023.2.14 大修，三个审稿人 2023.2.25 修回🙏 2023.3.2 送回审稿人！！ 2023.3.12 接受！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Sun Mar 12 17:59:47 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2102239, encodeId=738b210223955, content=我已经投出去快3个月了，一会在with editor, 一会在in peer view, 这是什么状态，请问我要不要催一下编辑？大家能给点建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79e94751065, createdName=adidas521521, createdTime=Wed Nov 23 21:00:45 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591166, encodeId=f68e591166ed, content=请问With editor一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f422038027, createdName=1821e90a65m, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854575, encodeId=b6448545e5c3, content=审稿速度:5.0 经验分享：5月份投稿，2个月的with editor才送审，期间大修返修过一次，10月11号小修修回，至今还是with editor，真的有点慢呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf15414154, createdName=ms3508121495608353, createdTime=Tue Oct 29 20:11:14 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583574, encodeId=35ce5835e448, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：降为2区了，再让这样灌水下去，3区都不保，很多1分水平的也给送审，还喜欢送给国人审！最近又审了3篇，2篇就cscd水平，让补一大堆数据给拒了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=)]

2017-11-06 nbcc14

7月28日投稿，10月13日回复审稿意见，28日修回，五天后接收，审稿人很认真负责。。。。。。

274 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192816, encodeId=3dc8219281653, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢组学 经验分享：2023.9.25投稿，2024.1.5第一次大修，1.30修回。2.8第二次大修，3.11接收。审稿人很负责, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Mar 12 16:44:35 CST 2024, time=2024-03-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=556031, encodeId=279e556031c3, content=历时4个多月，终于接收。 12.16投稿； 4.23大修； 5.9 返回； 5.11 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd6c2222639, createdName=mr.wu1992, createdTime=Sun May 13 12:19:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548940, encodeId=e85754894045, content=7月28日投稿，10月13日回复审稿意见，28日修回，五天后接收，审稿人很认真负责。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23de1733516, createdName=nbcc14, createdTime=Mon Nov 06 11:05:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843279, encodeId=fc598432e901, content=3月31投稿 4月6号外审 5月9号返回意见，小修 5月16号修回 5月21号接受 整体来说还是挺快的，给的意见也很中肯 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5414079, createdName=ms3478754100835653, createdTime=Mon May 21 23:52:17 CST 2018, time=2018-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181435, encodeId=42822181435d2, content=偏重的研究方向：药理 经验分享：11月24号投稿，12月16号收到大修通知，1月4号修回，1月10号accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Sat Jan 13 18:57:40 CST 2024, time=2024-01-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2119100, encodeId=8b9f2119100e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：食品;功能食品;肽 经验分享：Food Function 很快的一次经历，感谢编辑和审稿人 2023.1.09 投稿 2023.1.23 under review 第一审稿人出现 2023.1.26 第一审稿人完成 2023.1.29 第二第三审稿人出现 2023.2.9 第两个审稿人完成. 2023.2.14 大修，三个审稿人 2023.2.25 修回🙏 2023.3.2 送回审稿人！！ 2023.3.12 接受！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Sun Mar 12 17:59:47 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2102239, encodeId=738b210223955, content=我已经投出去快3个月了，一会在with editor, 一会在in peer view, 这是什么状态，请问我要不要催一下编辑？大家能给点建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79e94751065, createdName=adidas521521, createdTime=Wed Nov 23 21:00:45 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591166, encodeId=f68e591166ed, content=请问With editor一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f422038027, createdName=1821e90a65m, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854575, encodeId=b6448545e5c3, content=审稿速度:5.0 经验分享：5月份投稿，2个月的with editor才送审，期间大修返修过一次，10月11号小修修回，至今还是with editor，真的有点慢呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf15414154, createdName=ms3508121495608353, createdTime=Tue Oct 29 20:11:14 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583574, encodeId=35ce5835e448, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：降为2区了，再让这样灌水下去，3区都不保，很多1分水平的也给送审，还喜欢送给国人审！最近又审了3篇，2篇就cscd水平，让补一大堆数据给拒了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=)]

2018-05-21 ms3478754100835653

3月31投稿
4月6号外审
5月9号返回意见，小修
5月16号修回
5月21号接受
整体来说还是挺快的，给的意见也很中肯

62 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192816, encodeId=3dc8219281653, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢组学 经验分享：2023.9.25投稿，2024.1.5第一次大修，1.30修回。2.8第二次大修，3.11接收。审稿人很负责, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Mar 12 16:44:35 CST 2024, time=2024-03-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=556031, encodeId=279e556031c3, content=历时4个多月，终于接收。 12.16投稿； 4.23大修； 5.9 返回； 5.11 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd6c2222639, createdName=mr.wu1992, createdTime=Sun May 13 12:19:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548940, encodeId=e85754894045, content=7月28日投稿，10月13日回复审稿意见，28日修回，五天后接收，审稿人很认真负责。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23de1733516, createdName=nbcc14, createdTime=Mon Nov 06 11:05:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843279, encodeId=fc598432e901, content=3月31投稿 4月6号外审 5月9号返回意见，小修 5月16号修回 5月21号接受 整体来说还是挺快的，给的意见也很中肯 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5414079, createdName=ms3478754100835653, createdTime=Mon May 21 23:52:17 CST 2018, time=2018-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181435, encodeId=42822181435d2, content=偏重的研究方向：药理 经验分享：11月24号投稿，12月16号收到大修通知，1月4号修回，1月10号accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Sat Jan 13 18:57:40 CST 2024, time=2024-01-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2119100, encodeId=8b9f2119100e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：食品;功能食品;肽 经验分享：Food Function 很快的一次经历，感谢编辑和审稿人 2023.1.09 投稿 2023.1.23 under review 第一审稿人出现 2023.1.26 第一审稿人完成 2023.1.29 第二第三审稿人出现 2023.2.9 第两个审稿人完成. 2023.2.14 大修，三个审稿人 2023.2.25 修回🙏 2023.3.2 送回审稿人！！ 2023.3.12 接受！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Sun Mar 12 17:59:47 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2102239, encodeId=738b210223955, content=我已经投出去快3个月了，一会在with editor, 一会在in peer view, 这是什么状态，请问我要不要催一下编辑？大家能给点建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79e94751065, createdName=adidas521521, createdTime=Wed Nov 23 21:00:45 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591166, encodeId=f68e591166ed, content=请问With editor一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f422038027, createdName=1821e90a65m, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854575, encodeId=b6448545e5c3, content=审稿速度:5.0 经验分享：5月份投稿，2个月的with editor才送审，期间大修返修过一次，10月11号小修修回，至今还是with editor，真的有点慢呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf15414154, createdName=ms3508121495608353, createdTime=Tue Oct 29 20:11:14 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583574, encodeId=35ce5835e448, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：降为2区了，再让这样灌水下去，3区都不保，很多1分水平的也给送审，还喜欢送给国人审！最近又审了3篇，2篇就cscd水平，让补一大堆数据给拒了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=)]

2024-01-13 南大来自江苏省

偏重的研究方向：药理
经验分享：11月24号投稿，12月16号收到大修通知，1月4号修回，1月10号accept

25 0

[GetPortalCommentsPageByObjectIdResponse(id=2192816, encodeId=3dc8219281653, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢组学 经验分享：2023.9.25投稿，2024.1.5第一次大修，1.30修回。2.8第二次大修，3.11接收。审稿人很负责, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Mar 12 16:44:35 CST 2024, time=2024-03-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=556031, encodeId=279e556031c3, content=历时4个多月，终于接收。 12.16投稿； 4.23大修； 5.9 返回； 5.11 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd6c2222639, createdName=mr.wu1992, createdTime=Sun May 13 12:19:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548940, encodeId=e85754894045, content=7月28日投稿，10月13日回复审稿意见，28日修回，五天后接收，审稿人很认真负责。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23de1733516, createdName=nbcc14, createdTime=Mon Nov 06 11:05:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843279, encodeId=fc598432e901, content=3月31投稿 4月6号外审 5月9号返回意见，小修 5月16号修回 5月21号接受 整体来说还是挺快的，给的意见也很中肯 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5414079, createdName=ms3478754100835653, createdTime=Mon May 21 23:52:17 CST 2018, time=2018-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181435, encodeId=42822181435d2, content=偏重的研究方向：药理 经验分享：11月24号投稿，12月16号收到大修通知，1月4号修回，1月10号accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Sat Jan 13 18:57:40 CST 2024, time=2024-01-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2119100, encodeId=8b9f2119100e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：食品;功能食品;肽 经验分享：Food Function 很快的一次经历，感谢编辑和审稿人 2023.1.09 投稿 2023.1.23 under review 第一审稿人出现 2023.1.26 第一审稿人完成 2023.1.29 第二第三审稿人出现 2023.2.9 第两个审稿人完成. 2023.2.14 大修，三个审稿人 2023.2.25 修回🙏 2023.3.2 送回审稿人！！ 2023.3.12 接受！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Sun Mar 12 17:59:47 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2102239, encodeId=738b210223955, content=我已经投出去快3个月了，一会在with editor, 一会在in peer view, 这是什么状态，请问我要不要催一下编辑？大家能给点建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79e94751065, createdName=adidas521521, createdTime=Wed Nov 23 21:00:45 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591166, encodeId=f68e591166ed, content=请问With editor一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f422038027, createdName=1821e90a65m, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854575, encodeId=b6448545e5c3, content=审稿速度:5.0 经验分享：5月份投稿，2个月的with editor才送审，期间大修返修过一次，10月11号小修修回，至今还是with editor，真的有点慢呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf15414154, createdName=ms3508121495608353, createdTime=Tue Oct 29 20:11:14 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583574, encodeId=35ce5835e448, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：降为2区了，再让这样灌水下去，3区都不保，很多1分水平的也给送审，还喜欢送给国人审！最近又审了3篇，2篇就cscd水平，让补一大堆数据给拒了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=)]

2023-03-12 ms5000001105610949 来自广东省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：食品;功能食品;肽
经验分享：Food Function 很快的一次经历，感谢编辑和审稿人 2023.1.09 投稿 2023.1.23 under review 第一审稿人出现 2023.1.26 第一审稿人完成 2023.1.29 第二第三审稿人出现 2023.2.9 第两个审稿人完成. 2023.2.14 大修，三个审稿人 2023.2.25 修回🙏 2023.3.2 送回审稿人！！ 2023.3.12 接受！！

68 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192816, encodeId=3dc8219281653, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢组学 经验分享：2023.9.25投稿，2024.1.5第一次大修，1.30修回。2.8第二次大修，3.11接收。审稿人很负责, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Mar 12 16:44:35 CST 2024, time=2024-03-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=556031, encodeId=279e556031c3, content=历时4个多月，终于接收。 12.16投稿； 4.23大修； 5.9 返回； 5.11 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd6c2222639, createdName=mr.wu1992, createdTime=Sun May 13 12:19:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548940, encodeId=e85754894045, content=7月28日投稿，10月13日回复审稿意见，28日修回，五天后接收，审稿人很认真负责。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23de1733516, createdName=nbcc14, createdTime=Mon Nov 06 11:05:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843279, encodeId=fc598432e901, content=3月31投稿 4月6号外审 5月9号返回意见，小修 5月16号修回 5月21号接受 整体来说还是挺快的，给的意见也很中肯 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5414079, createdName=ms3478754100835653, createdTime=Mon May 21 23:52:17 CST 2018, time=2018-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181435, encodeId=42822181435d2, content=偏重的研究方向：药理 经验分享：11月24号投稿，12月16号收到大修通知，1月4号修回，1月10号accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Sat Jan 13 18:57:40 CST 2024, time=2024-01-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2119100, encodeId=8b9f2119100e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：食品;功能食品;肽 经验分享：Food Function 很快的一次经历，感谢编辑和审稿人 2023.1.09 投稿 2023.1.23 under review 第一审稿人出现 2023.1.26 第一审稿人完成 2023.1.29 第二第三审稿人出现 2023.2.9 第两个审稿人完成. 2023.2.14 大修，三个审稿人 2023.2.25 修回🙏 2023.3.2 送回审稿人！！ 2023.3.12 接受！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Sun Mar 12 17:59:47 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2102239, encodeId=738b210223955, content=我已经投出去快3个月了，一会在with editor, 一会在in peer view, 这是什么状态，请问我要不要催一下编辑？大家能给点建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79e94751065, createdName=adidas521521, createdTime=Wed Nov 23 21:00:45 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591166, encodeId=f68e591166ed, content=请问With editor一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f422038027, createdName=1821e90a65m, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854575, encodeId=b6448545e5c3, content=审稿速度:5.0 经验分享：5月份投稿，2个月的with editor才送审，期间大修返修过一次，10月11号小修修回，至今还是with editor，真的有点慢呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf15414154, createdName=ms3508121495608353, createdTime=Tue Oct 29 20:11:14 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583574, encodeId=35ce5835e448, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：降为2区了，再让这样灌水下去，3区都不保，很多1分水平的也给送审，还喜欢送给国人审！最近又审了3篇，2篇就cscd水平，让补一大堆数据给拒了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=)]

2022-11-23 adidas521521

我已经投出去快3个月了，一会在with editor, 一会在in peer view, 这是什么状态，请问我要不要催一下编辑？大家能给点建议吗

56 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192816, encodeId=3dc8219281653, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢组学 经验分享：2023.9.25投稿，2024.1.5第一次大修，1.30修回。2.8第二次大修，3.11接收。审稿人很负责, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Mar 12 16:44:35 CST 2024, time=2024-03-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=556031, encodeId=279e556031c3, content=历时4个多月，终于接收。 12.16投稿； 4.23大修； 5.9 返回； 5.11 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd6c2222639, createdName=mr.wu1992, createdTime=Sun May 13 12:19:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548940, encodeId=e85754894045, content=7月28日投稿，10月13日回复审稿意见，28日修回，五天后接收，审稿人很认真负责。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23de1733516, createdName=nbcc14, createdTime=Mon Nov 06 11:05:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843279, encodeId=fc598432e901, content=3月31投稿 4月6号外审 5月9号返回意见，小修 5月16号修回 5月21号接受 整体来说还是挺快的，给的意见也很中肯 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5414079, createdName=ms3478754100835653, createdTime=Mon May 21 23:52:17 CST 2018, time=2018-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181435, encodeId=42822181435d2, content=偏重的研究方向：药理 经验分享：11月24号投稿，12月16号收到大修通知，1月4号修回，1月10号accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Sat Jan 13 18:57:40 CST 2024, time=2024-01-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2119100, encodeId=8b9f2119100e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：食品;功能食品;肽 经验分享：Food Function 很快的一次经历，感谢编辑和审稿人 2023.1.09 投稿 2023.1.23 under review 第一审稿人出现 2023.1.26 第一审稿人完成 2023.1.29 第二第三审稿人出现 2023.2.9 第两个审稿人完成. 2023.2.14 大修，三个审稿人 2023.2.25 修回🙏 2023.3.2 送回审稿人！！ 2023.3.12 接受！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Sun Mar 12 17:59:47 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2102239, encodeId=738b210223955, content=我已经投出去快3个月了，一会在with editor, 一会在in peer view, 这是什么状态，请问我要不要催一下编辑？大家能给点建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79e94751065, createdName=adidas521521, createdTime=Wed Nov 23 21:00:45 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591166, encodeId=f68e591166ed, content=请问With editor一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f422038027, createdName=1821e90a65m, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854575, encodeId=b6448545e5c3, content=审稿速度:5.0 经验分享：5月份投稿，2个月的with editor才送审，期间大修返修过一次，10月11号小修修回，至今还是with editor，真的有点慢呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf15414154, createdName=ms3508121495608353, createdTime=Tue Oct 29 20:11:14 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583574, encodeId=35ce5835e448, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：降为2区了，再让这样灌水下去，3区都不保，很多1分水平的也给送审，还喜欢送给国人审！最近又审了3篇，2篇就cscd水平，让补一大堆数据给拒了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=)]

2020-05-18 1821e90a65m

请问With editor一般要多久？

162 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192816, encodeId=3dc8219281653, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢组学 经验分享：2023.9.25投稿，2024.1.5第一次大修，1.30修回。2.8第二次大修，3.11接收。审稿人很负责, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Mar 12 16:44:35 CST 2024, time=2024-03-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=556031, encodeId=279e556031c3, content=历时4个多月，终于接收。 12.16投稿； 4.23大修； 5.9 返回； 5.11 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd6c2222639, createdName=mr.wu1992, createdTime=Sun May 13 12:19:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548940, encodeId=e85754894045, content=7月28日投稿，10月13日回复审稿意见，28日修回，五天后接收，审稿人很认真负责。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23de1733516, createdName=nbcc14, createdTime=Mon Nov 06 11:05:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843279, encodeId=fc598432e901, content=3月31投稿 4月6号外审 5月9号返回意见，小修 5月16号修回 5月21号接受 整体来说还是挺快的，给的意见也很中肯 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5414079, createdName=ms3478754100835653, createdTime=Mon May 21 23:52:17 CST 2018, time=2018-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181435, encodeId=42822181435d2, content=偏重的研究方向：药理 经验分享：11月24号投稿，12月16号收到大修通知，1月4号修回，1月10号accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Sat Jan 13 18:57:40 CST 2024, time=2024-01-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2119100, encodeId=8b9f2119100e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：食品;功能食品;肽 经验分享：Food Function 很快的一次经历，感谢编辑和审稿人 2023.1.09 投稿 2023.1.23 under review 第一审稿人出现 2023.1.26 第一审稿人完成 2023.1.29 第二第三审稿人出现 2023.2.9 第两个审稿人完成. 2023.2.14 大修，三个审稿人 2023.2.25 修回🙏 2023.3.2 送回审稿人！！ 2023.3.12 接受！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Sun Mar 12 17:59:47 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2102239, encodeId=738b210223955, content=我已经投出去快3个月了，一会在with editor, 一会在in peer view, 这是什么状态，请问我要不要催一下编辑？大家能给点建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79e94751065, createdName=adidas521521, createdTime=Wed Nov 23 21:00:45 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591166, encodeId=f68e591166ed, content=请问With editor一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f422038027, createdName=1821e90a65m, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854575, encodeId=b6448545e5c3, content=审稿速度:5.0 经验分享：5月份投稿，2个月的with editor才送审，期间大修返修过一次，10月11号小修修回，至今还是with editor，真的有点慢呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf15414154, createdName=ms3508121495608353, createdTime=Tue Oct 29 20:11:14 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583574, encodeId=35ce5835e448, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：降为2区了，再让这样灌水下去，3区都不保，很多1分水平的也给送审，还喜欢送给国人审！最近又审了3篇，2篇就cscd水平，让补一大堆数据给拒了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=)]

2019-10-29 ms3508121495608353

审稿速度:5.0
经验分享：5月份投稿，2个月的with editor才送审，期间大修返修过一次，10月11号小修修回，至今还是with editor，真的有点慢呀。

50 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192816, encodeId=3dc8219281653, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢组学 经验分享：2023.9.25投稿，2024.1.5第一次大修，1.30修回。2.8第二次大修，3.11接收。审稿人很负责, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Mar 12 16:44:35 CST 2024, time=2024-03-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=556031, encodeId=279e556031c3, content=历时4个多月，终于接收。 12.16投稿； 4.23大修； 5.9 返回； 5.11 接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd6c2222639, createdName=mr.wu1992, createdTime=Sun May 13 12:19:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548940, encodeId=e85754894045, content=7月28日投稿，10月13日回复审稿意见，28日修回，五天后接收，审稿人很认真负责。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23de1733516, createdName=nbcc14, createdTime=Mon Nov 06 11:05:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843279, encodeId=fc598432e901, content=3月31投稿 4月6号外审 5月9号返回意见，小修 5月16号修回 5月21号接受 整体来说还是挺快的，给的意见也很中肯 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5414079, createdName=ms3478754100835653, createdTime=Mon May 21 23:52:17 CST 2018, time=2018-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2181435, encodeId=42822181435d2, content=偏重的研究方向：药理 经验分享：11月24号投稿，12月16号收到大修通知，1月4号修回，1月10号accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Sat Jan 13 18:57:40 CST 2024, time=2024-01-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2119100, encodeId=8b9f2119100e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：食品;功能食品;肽 经验分享：Food Function 很快的一次经历，感谢编辑和审稿人 2023.1.09 投稿 2023.1.23 under review 第一审稿人出现 2023.1.26 第一审稿人完成 2023.1.29 第二第三审稿人出现 2023.2.9 第两个审稿人完成. 2023.2.14 大修，三个审稿人 2023.2.25 修回🙏 2023.3.2 送回审稿人！！ 2023.3.12 接受！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e55679937, createdName=ms5000001105610949, createdTime=Sun Mar 12 17:59:47 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2102239, encodeId=738b210223955, content=我已经投出去快3个月了，一会在with editor, 一会在in peer view, 这是什么状态，请问我要不要催一下编辑？大家能给点建议吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79e94751065, createdName=adidas521521, createdTime=Wed Nov 23 21:00:45 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591166, encodeId=f68e591166ed, content=请问With editor一般要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f422038027, createdName=1821e90a65m, createdTime=Mon May 18 00:00:00 CST 2020, time=2020-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854575, encodeId=b6448545e5c3, content=审稿速度:5.0 经验分享：5月份投稿，2个月的with editor才送审，期间大修返修过一次，10月11号小修修回，至今还是with editor，真的有点慢呀。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf15414154, createdName=ms3508121495608353, createdTime=Tue Oct 29 20:11:14 CST 2019, time=2019-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583574, encodeId=35ce5835e448, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：降为2区了，再让这样灌水下去，3区都不保，很多1分水平的也给送审，还喜欢送给国人审！最近又审了3篇，2篇就cscd水平，让补一大堆数据给拒了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/03/a49c0c976fe7f81b1448833c8538aa24.jpg, createdBy=cb9a1630518, createdName=Rtase, createdTime=Sat Jan 18 00:00:00 CST 2020, time=2020-01-18, status=1, ipAttribution=)]

2020-01-18 Rtase

审稿速度:2.0 | 投稿命中率:75.0
经验分享：降为2区了，再让这样灌水下去，3区都不保，很多1分水平的也给送审，还喜欢送给国人审！最近又审了3篇，2篇就cscd水平，让补一大堆数据给拒了！

103 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务